NCT00733538 2024-04-12
IFM-01-04
Centre Hospitalier Universitaire de Nice
Phase 4 Completed
Clinical Trials
8 trialsNCT02286830 2023-02-17
Magnolia
Odense University Hospital
Phase 4 Completed
NCT00622505 2021-05-26
Z-MARK
Novartis
Phase 4 Completed
NCT01087008 2020-04-06
AZABACHE
PETHEMA Foundation
Phase 4 Completed
NCT00434447 2017-02-27
Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases
Novartis
Phase 4 Completed
NCT00242528 2015-04-14
Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.
Novartis
Phase 4 Withdrawn
NCT00029224 2012-02-01
Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions
Novartis
Phase 4 Completed
NCT00104104 2011-06-29
A Multiple Myeloma Trial in Patients With Bone Metastases
Novartis
Phase 4 Completed